Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands |
Total |
Preferred Stock |
Common Stock |
Capital in Excess of Par Value |
Accumulated Deficit |
AOCIL |
| Beginning balance, value at Dec. 31, 2021 |
$ 3,999,799
|
$ 166,177
|
$ 6,385
|
$ 6,673,440
|
$ (2,840,356)
|
$ (5,847)
|
| Preferred shares outstanding, beginning balance at Dec. 31, 2021 |
|
6,900,000
|
|
|
|
|
| Common shares outstanding, beginning balance at Dec. 31, 2021 |
|
|
127,699,235
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net income (loss) |
56,056
|
|
|
|
56,056
|
|
| Dividends declared on preferred stock |
(2,588)
|
|
|
|
(2,588)
|
|
| Net income attributable to common stockholders |
53,468
|
|
|
|
53,468
|
|
| Other comprehensive income (Loss) |
702
|
|
|
|
|
702
|
| Dividends declared on common stock |
(85,688)
|
|
|
|
(85,688)
|
|
| Tax withholdings related to net stock settlements |
(6,410)
|
|
$ (2)
|
|
(6,408)
|
|
| Tax withholdings related to net stock settlements (in shares) |
|
|
(39,028)
|
|
|
|
| Issuance of shares of common stock, net |
299,768
|
|
$ 328
|
299,440
|
|
|
| Issuance of shares of common stock, net (in shares) |
|
|
6,559,406
|
|
|
|
| Stock-based compensation, net |
3,529
|
|
$ 4
|
4,021
|
(496)
|
|
| Stock-based compensation, net (in shares) |
|
|
86,888
|
|
|
|
| Ending balance, value at Mar. 31, 2022 |
4,265,168
|
$ 166,177
|
$ 6,715
|
6,976,901
|
(2,879,480)
|
(5,145)
|
| Preferred shares outstanding, ending balance at Mar. 31, 2022 |
|
6,900,000
|
|
|
|
|
| Common shares outstanding, ending balance at Mar. 31, 2022 |
|
|
134,306,501
|
|
|
|
| Beginning balance, value at Dec. 31, 2021 |
3,999,799
|
$ 166,177
|
$ 6,385
|
6,673,440
|
(2,840,356)
|
(5,847)
|
| Preferred shares outstanding, beginning balance at Dec. 31, 2021 |
|
6,900,000
|
|
|
|
|
| Common shares outstanding, beginning balance at Dec. 31, 2021 |
|
|
127,699,235
|
|
|
|
| Ending balance, value at Dec. 31, 2022 |
$ 4,561,316
|
$ 166,177
|
$ 7,062
|
7,285,629
|
(2,931,640)
|
34,088
|
| Preferred shares outstanding, ending balance at Dec. 31, 2022 |
6,900,000
|
6,900,000
|
|
|
|
|
| Common shares outstanding, ending balance at Dec. 31, 2022 |
141,231,219
|
|
141,231,219
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net income (loss) |
$ 96,173
|
|
|
|
96,173
|
|
| Dividends declared on preferred stock |
(2,588)
|
|
|
|
(2,588)
|
|
| Net income attributable to common stockholders |
93,585
|
|
|
|
93,585
|
|
| Other comprehensive income (Loss) |
(10,586)
|
|
|
|
|
(10,586)
|
| Dividends declared on common stock |
(93,675)
|
|
|
|
(93,675)
|
|
| Tax withholdings related to net stock settlements |
(1,312)
|
|
$ (2)
|
|
(1,310)
|
|
| Tax withholdings related to net stock settlements (in shares) |
|
|
(30,279)
|
|
|
|
| Stock-based compensation, net |
4,571
|
|
$ 5
|
5,225
|
(659)
|
|
| Stock-based compensation, net (in shares) |
|
|
98,982
|
|
|
|
| Ending balance, value at Mar. 31, 2023 |
$ 4,553,899
|
$ 166,177
|
$ 7,065
|
$ 7,290,854
|
$ (2,933,699)
|
$ 23,502
|
| Preferred shares outstanding, ending balance at Mar. 31, 2023 |
6,900,000
|
6,900,000
|
|
|
|
|
| Common shares outstanding, ending balance at Mar. 31, 2023 |
141,299,922
|
|
141,299,922
|
|
|
|